Quimby SJ - Search Results

1

Na+-dependent high affinity binding of [3H]LY515300, a 3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid receptor inverse agonist.

Statnick MA, Suter TM, Gackenheimer SL, Emmerson PJ, Quimby SJ, Gehlert DR, Wheeler WJ, Mitch CH. Statnick MA, et al. Among authors: quimby sj. Eur J Pharmacol. 2003 Dec 15;482(1-3):139-50. doi: 10.1016/j.ejphar.2003.09.043. Eur J Pharmacol. 2003. PMID: 14660015

2

Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.

Gackenheimer SL, Suter TM, Pintar JE, Quimby SJ, Wheeler WJ, Mitch CH, Gehlert DR, Statnick MA. Gackenheimer SL, et al. Among authors: quimby sj. Neuropeptides. 2005 Dec;39(6):559-67. doi: 10.1016/j.npep.2005.09.006. Epub 2005 Nov 9. Neuropeptides. 2005. PMID: 16289278

3

Structure activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2.

Takeuchi K, Holloway WG, Mitch CH, Quimby SJ, McKinzie JH, Suter TM, Statnick MA, Surface PL, Emmerson PJ, Thomas EM, Siegel MG. Takeuchi K, et al. Among authors: quimby sj. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6841-6. doi: 10.1016/j.bmcl.2007.10.025. Epub 2007 Oct 17. Bioorg Med Chem Lett. 2007. PMID: 17980586

4

Discovery of aminobenzyloxyarylamides as κ opioid receptor selective antagonists: application to preclinical development of a κ opioid receptor antagonist receptor occupancy tracer.

Mitch CH, Quimby SJ, Diaz N, Pedregal C, de la Torre MG, Jimenez A, Shi Q, Canada EJ, Kahl SD, Statnick MA, McKinzie DL, Benesh DR, Rash KS, Barth VN. Mitch CH, et al. Among authors: quimby sj. J Med Chem. 2011 Dec 8;54(23):8000-12. doi: 10.1021/jm200789r. Epub 2011 Oct 26. J Med Chem. 2011. PMID: 21958337

5

SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists.

Díaz N, Benvenga M, Emmerson P, Favors R, Mangold M, McKinzie J, Patel N, Peters S, Quimby S, Shannon H, Siegel M, Statnick M, Thomas E, Woodland J, Surface P, Mitch C. Díaz N, et al. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3844-8. doi: 10.1016/j.bmcl.2005.05.123. Bioorg Med Chem Lett. 2005. PMID: 15993591

6

Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.

Shannon HE, Bymaster FP, Hendrix JC, Quimby SJ, Mitch CH. Shannon HE, et al. Among authors: quimby sj. Psychopharmacology (Berl). 1995 Jan;117(2):208-15. doi: 10.1007/BF02245189. Psychopharmacology (Berl). 1995. PMID: 7753969

7

LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.

Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS, Shaw DB, Sahr AE, Adams BL, Quimby SJ, Diaz N, Jimenez A, Pedregal C, Mitch CH, Knopp KL, Anderson WH, Cramer JW, McKinzie DL. Rorick-Kehn LM, et al. Among authors: quimby sj. Neuropharmacology. 2014 Feb;77:131-44. doi: 10.1016/j.neuropharm.2013.09.021. Epub 2013 Sep 23. Neuropharmacology. 2014. PMID: 24071566

8

Effect of 4-(4-methoxy-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine , an analog of MPTP, on mouse heart norepinephrine and brain catecholamines.

Hemrick-Luecke SK, Mitch CH, Quimby SJ, Fuller RW. Hemrick-Luecke SK, et al. Among authors: quimby sj. Neurochem Int. 1993 Nov;23(5):467-70. doi: 10.1016/0197-0186(93)90131-n. Neurochem Int. 1993. PMID: 8251928

9

Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: potential application for the treatment of irritable bowel syndrome.

Mitch CH, Brown TJ, Bymaster FP, Calligaro DO, Dieckman D, Merrit L, Peters SC, Quimby SJ, Shannon HE, Shipley LA, Ward JS, Hansen K, Olesen PH, Sauerberg P, Sheardown MJ, Swedberg MD, Suzdak P, Greenwood B. Mitch CH, et al. Among authors: quimby sj. J Med Chem. 1997 Feb 14;40(4):538-46. doi: 10.1021/jm9602470. J Med Chem. 1997. PMID: 9046345

10

Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depression.

Dressman BA, Tromiczak EG, Chappell MD, Tripp AE, Quimby SJ, Vetman T, Fivush AM, Matt J, Jaramillo C, Li R, Khilevich A, Blanco MJ, Smith SC, Carpintero M, de Diego JE, Barberis M, García-Cerrada S, Soriano JF, Schkeryantz JM, Witkin JM, Wafford KA, Seidel W, Britton T, Overshiner CD, Li X, Wang XS, Heinz BA, Catlow JT, Swanson S, Bedwell D, Ornstein PL, Mitch CH. Dressman BA, et al. Among authors: quimby sj. Bioorg Med Chem Lett. 2016 Dec 1;26(23):5663-5668. doi: 10.1016/j.bmcl.2016.10.067. Epub 2016 Oct 25. Bioorg Med Chem Lett. 2016. PMID: 27836401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters